Navigation Links
Risperidone in Medical News

Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL

COLUMBUS, Ohio, July 29 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Risperidone Oral Solution, 1mg/mL by the U.S. Food and Drug Administration. The product is available in 30mL bottles for immediate shipment to...

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

...products such as tramadol APAP and fluoxetine HCl, as well as the launch of risperidone ODT in June 2009. Megace(R) ES: Net sales were $17.1 m...he second half of 2010. Par successfully launched five strengths of risperidone ODT, a generic version of Risperdal(R) M-TAB, during the second quarter, a...

Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia

...bing trends in newly diagnosed schizophrenia patients. Abilify is second to risperidone (Janssen's Risperdal, generics) in first and second lines of therapy and le...ased uptake in early lines of therapy, surveyed psychiatrists indicate that risperidone and Zyprexa will lose the most share. These data indicate that marketers of...

Seroquel's First- and Second-Line Patient Share Has Grown Since Last Year's Analysis of Prescribing Trends in Bipolar Disorder

... Although risperidone Is Now Available In Generics, There Is No Clear Ev...thms in Bipolar Disorder also finds that although risperidone is now available in generics there is no clear evi...nt of surveyed physicians do not prescribe generic risperidone first-line and only one-third of surveyed physicia...

New tool to improve patient understanding of long-acting injectable antipsychotic therapies (LAT) unveiled in April issue of Psychiatry 2009

... in approaching a recommendation and have the possibility to help more patients with schizophrenia as we work together to control their symptoms." risperidone long-acting therapy (RLAT, or RISPERDAL CONSTA), for the treatment of symptoms of schizophrenia, is one of several long-acting injectable products ava...

New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia

...) drug-delivery technology. Using this technology, risperidone is encapsulated in microspheres made of a biodegra...tients with dementia-related psychosis taking oral risperidone in clinical trials. The incidence of CAEs with risperidone was significantly higher than with placebo. RISPER...

Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting

...a meta-analysis of olanzapine LAI, olanzapine and haloperidol data. Additionally, a cost-effectiveness simulation analysis comparing olanzapine LAI to risperidone LAI, haloperidol LAI and oral olanzapine was presented. About HGKB The primary objective of this ongoing open-label study is to examine th...

FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder

... treatment for mental illness, and the approval of risperidone long-acting treatment for Bipolar Disorder is exci...information. About RISPERDAL(R) CONSTA(R) risperidone long-acting treatment (RLAT) is a long-acting injectable form of risperidone that was developed utilizing Alkermes' proprietary...

FDA Panel Snubs Seroquel as 1st Choice Depression Treatment

...he overall odds of a heart problem for patients taking this class of medications -- which also includes clozapine (Clozaril), olanzapine (Zyprexa) and risperidone (Risperdal) -- were probably low, and the drugs remained appropriate for certain patients. Still, doctors, families and patients should be cautious, a...

Combating weight gain caused by antipsychotic treatments

... Philadelphia, PA, March 26, 2009 Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behaviora...
Risperidone in Medical Technology

Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study

Separate Study Showed Significantly Improved Functioning Within Three Months WASHINGTON, May 6 /PRNewswire-FirstCall/ -- Nearly half of patients with schizophrenia fail to remain on their medication treatment, which can result in a relapse of symptoms (1,2). To...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

...) drug-delivery technology. Using this technology, risperidone is encapsulated in microspheres made of a biodegra...tients with dementia-related psychosis taking oral risperidone in clinical trials. The incidence of CAEs with risperidone was significantly higher than with placebo. RISPER...

Critical Pharmaceuticals Enter Sustained Release hGH Arena

... The plan is now to take this product into clinic either by ourselves or in partnership. We are also in preclinical development with sustained release risperidone and, demonstrating the versatility of our technology platform, a once-daily nasal formulation of hGH." About Critical Pharmaceuticals Critical Pha...

Vanda Presents Phase III Iloperidone Efficacy Data

...4 mg/day; similar reductions in BPRS scores were observed at six weeks for iloperidone in doses of 20-24 mg/day, as compared to the active comparators risperidone and haloperidol. The analysis further demonstrated that iloperidone had a favorable safety profile, most notably with regard to extrapyramidal symptom...

Acadia Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial

...the co-therapy arm combining ACP-103 with low-dose risperidone demonstrated a statistically significant improveme...limitations. The use of ACP-103 in co-therapy with risperidone or other modern atypical antipsychotics may result...w-dose risperidone (ACP-103/risperidone); low-dose risperidone plus placebo (risperidone LD); high-dose...

ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research

...-therapy arm combining ACP-103 with risperidone (2 mg) had significantly lower prolactin levels after 42 days of treatment compared to patients in the risperidone (6 mg) plus placebo arm (p=0.0001). The condition of elevated prolactin is a commonly observed side effect of antipsychotic therapy and may adversely ...

Antipsychotic Iloperidone Results Show Favorable Akathisia Profile

...peridone (12-16 mg/d, 20-24 mg/d) with placebo and risperidone controls (6- 8 mg/d). When akathisia was measured ...0.04; 8%, p=0.004), compared to placebo (20%). The risperidone group (20%, p=1.00) was equal to placebo. Three times as many patients in the risperidone group (22%), compared to placebo (7%), received an...

Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant

...he deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Neither paliperidone nor risperidone are approved for the treatment of patients with Dementia-Related Psychosis. Commonly observed adverse events: The most commonly observed adverse eve...
Risperidone in Biological News

Risks and benefits of antipsychotics in children and adolescents

... psychosis patients, weight gain was also greater with olanzapine than with risperidone or quetiapine (Castro-Fornieles et al., in press). Weight gain in children ...ogical side effects (especially hypokinesia/akinesia) were more common with risperidone (Castro-Fornieles et al., in press). Antipsychotics have shown efficacy...

Chemical maps hint at drug's effects on schizophrenia

...d 300 different lipids in blood drawn from 50 patients with schizophrenia before and after treatment with the atypical antipsychotic drugs olanzapine, risperidone or aripiprazole. Lipomics specializes in diagnostic discovery with an emphasis on lipid metabolism. Atypical antipsychotics, a newer group of prescrip...

Studies look at how genes affect antipsychotic drug response

...irst episode of schizophrenia who are treated with risperidone for six weeks as part of UIC's First Episode Progr...op is also beginning a second project to study how risperidone may elevate prolactin levels and cause weight gain... treated as safely as possible. "Understanding risperidone pharmacogenetics and whether some individuals are ...
Risperidone in Biological Technology

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

MONTREUX, Switzerland, Feb. 4 /PRNewswire/ -- Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients ...

Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting

... presented at scientific poster sessions on Monday, May 18 from 9:00 am to 10:30 am. NR1-033 Efficacy of Iloperidone is Comparable to risperidone in Analyses of a Placebo- and Risperidone-Controlled Clinical Trial for Schizophrenia. NR1-026 The Comparative Efficacy of Iloperid...

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

...ore than 80 countries worldwide. Using Alkermes' proprietary Medisorb(R) drug-delivery technology, the RISPERDAL(R) CONSTA(R) formulation encapsulates risperidone in microspheres made of a biodegradable polymer, which are suspended in a water-based solution and injected into the muscle. Laboratory and clinical r...

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

...tate reduced symptoms, non-inferiority relative to risperidone LAT was not demonstrated. Safety findings in both ...lly supplemented placebo (PP+Pbo) or flexible dose risperidone LAT plus orally supplemented risperidone (LAT RIS+RIS). All injections were administered i...
Other Tags
(Date:7/12/2014)... 12, 2014 The rise in the ... for new advanced network architectures to suit the upsurge. ... industry with increasing cloud storage technologies. The data traffic ... more mobility devices. This has resulted in larger and ... driving forces for the SDN market. , The North ...
(Date:7/12/2014)... 2014 Demand Response Management Systems is ... in reducing the imbalance between energy supply and demand. ... been rolled out (due to increasing pressure on the ... helps in controlling residential appliances and thermostats for load ... North American region, and with government mandates and benefits ...
(Date:7/12/2014)... (HealthDay News) -- If you make exercise fun, you,ll eat ... experiment, 56 adults were led on a 1.4-mile walk and ... a scenic walk. The participants were given lunch after the ... outing ate 35 percent more chocolate pudding for dessert than ... In another experiment, 46 adults were given mid-afternoon snacks after ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 Using ... so one of two inventors from Ashland, Va., decided ... do this. "This inspired us to conceive of our ... of the patent-pending KIDNEY KOVER, which provides an inconspicuous ... It avoids embarrassment, as well as promotes comfort and ...
(Date:7/12/2014)... “Critical Care Therapeutics in Major Developed ... PCCs and Recombinant Products to Drive Market,” which ... in the US, UK, France, Germany, Italy, Spain, ... of market size for 2013, along with market ... that are being treated using the five major ...
Breaking Medicine News(10 mins):Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Make Exercise Fun, Eat Less Afterwards 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6
(Date:7/10/2014)... SPRINGS, Colo. , June 27, 2014 /PRNewswire/ ... that the National Institute of Standards and Technology ... 10 of its academic research and forensic science ... (FSSB).  The Board is an element of the ... AAFS members are among the first appointments made ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... , Unisys Nederland N.V., today announced that it has been ... implement and manage a new Basic Provision Biometrics solution for ... Unisys won the contract with a solution based on ... software. The term of the contract is up to seven ...
(Date:7/10/2014)... , July 3, 2014 Research and ... of the "Global Gesture Recognition & Touch-Less ... Forecasts to 2020" report to their offering ... Global Gesture Recognition & Touch-Less Sensing Market to ... for a while, but the companies were unable ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
Other Contents